We support the Canadian ecosystem in the development, translation and implementation of medical device innovations. Relying on scientific fundamentals and biomedical engineering expertise, we maintain a deep understanding of the research path from idea to market. To achieve this, we rely on an extensive collaborative network of industry, clinicians, academics and government collaborators.
Services and information
Facilities
- Polymer lab-on-a-chip and microfluidics laboratories
- Digital health software platforms, developed to industry standards
- Materials processing and manufacturing laboratory
Research focus
- Point-of-care (POC) diagnostics
- Fast-result, low-cost polymer microfluidics innovations scalable for mass production
- Select applications: Molecular diagnostics, cell and gene therapy, and drug discovery
- Digital therapeutics
- Evidence-based biomedical software innovations developed to industry standards
- Select applications: Patient monitoring, assessment and therapy, clinician decision support
Expertise
- Micro-nanofabrication for bioanalytical devices
- Microfluidics and lab-on-chip systems
- Devices for in-vitro diagnostics, organ-on-chip and cell therapy
- Biomedical software, data science and extended reality (xR) development
- Cognitive and psycho-motor human-machine interactions
- Digitally augmented physiological and neurological sensing
Collaboration centres and partnerships
- Centre for Research and Applications in Fluidic Technologies (CRAFT)
- A national collaboration centre with the University of Toronto – enabling R&D in microfluidic lab-on-chip technologies.
- Collaborative Unit for Translational Research (CUTR)
- A collaboration centre with CHU Sainte-Justine enabling critical research for improved pediatric care.
- Cognitive care network
- A network with world-leading clinical sites across Canada, to deliver digital therapeutics for a variety of neurological and mental health conditions.
- LIFT: An industry-facing initiative targeting the translation of NRC innovations in lab-on-a-chip to market
- V-Care: An industry-facing initiative targeting the translation of NRC innovations in virtual care to market
Research activities
- Legend of Evelys: interactive role playing mobile application
- Space and remote communities bio-analytics
- Living micro-systems / organ-on-a-chip devices
- Personalized digital therapeutics for cognitive, psychiatric and movement disorders
- Contactless and remote patient monitoring
Research and technical services
- Biomedical device and software R&D
- Prototype design and development
- Implementation of innovative concepts into product lines
- Testing and manufacturability
- Technical support and advice
Why work with us
We believe we can support the growth of Canada's medical device ecosystem, given our:
- Deep biomedical acumen, commitment to research excellence and translation to clinical use
- strong connectivity with clinicians, industry, academia and government
- track record of ideation-to-market, with the ability to skillfully navigate at any point of the translation
Feature
Related links
- New: Webinar - The NRC and MedTech Canada present: How to Succeed in a Post-Pandemic MedTech Marketplace: Building on Canada’s Strengths
- Advisory Board members
- A digital coach to help overworked healthcare workers get a good night’s sleep
- Cybersecurity for medical devices
- Shrinking entire medical labs onto chips with the help of nanotechnology
- Canadian innovation in food safety poised to hit commercial market
Contact us
Claude Larose, Business Advisor
Email: Claude.Larose@cnrc-nrc.gc.ca
LinkedIn: Claude Larose
Our experts
Research publications
- On-the-fly phase transition and density changes of aqueous two-phase systems on a centrifugal microfluidic platform
- Enrichment of peripheral blood mononuclear cells from large volumes of blood using centrifugal microfluidics
- Flow through target bacteria capture, lysis and DNA extraction using magnetic clouds
- Programmable density-based fractionation in centrifugal microfluidics
- Aqueous two-phase system-assisted blood fractionation and cell isolation in centrifugal microfluidics